Building better oncology tools
Company Overview
AccuStem is a clinical stage diagnostics company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology- to empower patients and their care team with critical answers and tools and drive innovation in healthcare.
Latest news
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
London, UK and Phoenix, AZ (June 9, 2022) - AccuStem Sciences, Inc. (OTCQB: ACUT), a life [...]
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
London, UK and Phoenix, AZ (April 28, 2022)- AccuStem Sciences, Inc. (OTCQB: ACUT), a life [...]
AccuStem Announces DTC Eligibility
London, UK and Phoenix, AZ (April 14, 2022)- AccuStem Sciences, Inc. (OTCQB: ACUT), a life [...]
Information For Shareholders Regarding Accustem Shares
Holders of record of shares of Accustem Sciences Inc should refer to the below instructions regarding the process to receive their shares. Please contact Philadelphia Stock Transfer (“PST”) with any questions regarding the process.